A Randomized, Controlled Study of a Simple, Once-Daily Regimen of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated, Multidrug-Resistant Falciparum Malaria-Reference-Cited by-同舟云学术

A Randomized, Controlled Study of a Simple, Once-Daily Regimen of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated, Multidrug-Resistant Falciparum Malaria

Published:2005-08-15 Issue:4 Volume:41 Page:425-432
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Ashley E. A.,McGready R.,Hutagalung R.,Phaiphun L.,Slight T.,Proux S.,Thwai K. L.,Barends M.,Looareesuwan S.,White N. J.,Nosten F.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/41/4/425/963840/41-4-425.pdf

Reference13 articles.

1. Efficacy and Safety of Dihydroartemisinin‐Piperaquine (Artekin) in Cambodian Children and Adults with Uncomplicated Falciparum Malaria

2. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial

3. Antimalarial drug resistance and combination chemotherapy

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artesunate-mefloquine therapy for uncomplicated Plasmodium falciparum malaria: an updated systematic review and meta-analysis of efficacy and safety;Transactions of the Royal Society of Tropical Medicine and Hygiene;2023-09-29

2. Prevalence of mutations in the cysteine desulfurase IscS (Pfnfs1) gene in recurrent Plasmodium falciparum infections following artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) treatment in Matayos, Western Kenya;Malaria Journal;2023-05-19

3. Pilot study: bioequivalence of dihydroartemisinin in dihydroartemisinin-piperaquine tablet generic formulation in healthy Indonesian volunteers;NAGOYA J MED SCI;2023

4. Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria;PLOS ONE;2023-02-23

5. Observation of Malaria Treatment with Dihydroartemisinin-Piperaquine Combination at Primary Health Care;Turkish Journal of Parasitology;2022-05-23